Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Coagulation Factor Ix Recombinant

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Alprolix

    02 6BeneFIX

    03 1Benefix

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Alprolix

    France
    arrow
    BioAsia
    Not Confirmed
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Sanofi

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 553

    2021 Revenue in Millions : 456

    Growth (%) : 21

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Alprolix

    France
    arrow
    BioAsia
    Not Confirmed
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Sanofi

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2023 Revenue in Millions : 583

    2022 Revenue in Millions : 553

    Growth (%) : 7

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Alprolix

    France
    arrow
    BioAsia
    Not Confirmed
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Sanofi

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 322

    2017 Revenue in Millions : 0

    Growth (%) : NA

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    BioAsia
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    BioAsia
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2019 Revenue in Millions : 488

    2018 Revenue in Millions : 554

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    BioAsia
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    BioAsia
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2020 Revenue in Millions : 454

    2019 Revenue in Millions : 488

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    BioAsia
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    BioAsia
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Disorders

    Currency : USD

    2021 Revenue in Millions : 438

    2020 Revenue in Millions : 454

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    BioAsia
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    BioAsia
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2022 Revenue in Millions : 425

    2021 Revenue in Millions : 438

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Alprolix

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    arrow
    BioAsia
    Not Confirmed

    Brand Name : Alprolix

    Sweden
    arrow
    BioAsia
    Not Confirmed

    Swedish Orphan Biovitrum AB

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 178

    2021 Revenue in Millions : 190

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : BeneFIX

    Coagulation Factor IX

    arrow
    BioAsia
    Not Confirmed

    Brand Name : BeneFIX

    U.S.A
    arrow
    BioAsia
    Not Confirmed

    Pfizer Inc.

    Coagulation Factor IX

    Main Therapeutic Indication : Rare Diseases

    Currency : USD

    2023 Revenue in Millions : 424

    2022 Revenue in Millions : 425

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Alprolix

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    arrow
    BioAsia
    Not Confirmed

    Brand Name : Alprolix

    U.S.A
    arrow
    BioAsia
    Not Confirmed

    Biogen

    Coagulation Factor IX (Recombinant), Fc Fusion Protein

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 0

    2017 Revenue in Millions : 26

    Growth (%) : -100%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF